Here are 12 key market players:
1. Arthrex
2. Arteriocyte Medical Systems
3. DePuy Synthes
4. Biomet
5. Cesca Therapeutics
6. Dr. PRP America
7. EmCyte Corp.
8. AdiStem
9. Exactech
10. Nuo Therapeutics
11. Regen Lab
12. Harvest Technologies Corp.
More articles on biologics:
RTI Surgical & Aziyo Biologics ink deal: 4 things to know
Asterias Biotherapeutics’ stem cell-derived treatment for spinal cord injury holds promise: 4 things to know
Ortho RTi receives extension on 2.1M+ warrants: 3 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
